Message by President Verona and CdS
Milan, 24 September 2022
Dear Researchers
on behalf of the Consiglio di Sorveglianza of the Foundation that I chair, I would like to confirm that I have received and read with great attention the letter addressed to us in recent days by hundreds of Italian researchers, in which they reaffirm the great interest that the national scientific community has in the initiative that, as prescribed by Law 160/2019, Human Technopole is pursuing for the creation of an infrastructural hub to support national research in the field of life sciences.
The Consiglio di Sorveglianza would like to thank all researchers who wished to publicly attest their interest and trust in the activity that the Board itself is overseeing – as prescribed by the Convenzione signed with the founding Ministries on 30 December 2020 – for the definition of the implementation plan of the National Platforms, on the basis of the results shared in the Final Report following the public consultation conducted to identify the priorities perceived by the national scientific community.
Best regards,
Prof. Gianmario Verona
President of the Consiglio di Sorveglianza of the Human Technopole Foundation
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.